Analysis of influencing factors on survival time of patients with hepatocellular carcinoma in BCLC-C stage treated by transcatheter arterial chemoembolization combined with traditional Chinese medicine
Objective To explore the influencing factors of survival time of patients with hepatocellular carcinoma(HCC)in Barcelona Clinic Liver Cancer(BCLC)-C stage treated by transcatheter arterial chemoembolization(TACE)combined with traditional Chinese medicine.Methods A total of 56 patients with HCC in BCLC-C stage in Hubei Provincial Hospital of Traditional Chinese Medicine from January 1,2017 to March 31,2022 were selected and divided into long-term survival group(18 cases)and non-long-term survival group(38 cases)according to whether the survival time was≥22 months.The influencing factors of survival time of the patients treated by TACE combined with traditional Chinese medicine was analyzed by multivariate logistic regression equation.Results Among the 56 patients,there were 48 males and eight females,aged from 31 to 81 years,with an average of(59.8±12.5)years.The results of multivariate logistic regression equation analysis showed that the higher the body weight(OR = 1.125,95%CI:1.014-1.247,P = 0.026),the longer the taking time of traditional Chinese medicine decoction(OR = 1.004,95%CI:1.000-1.007,P = 0.045),the higher the prothrombin activity(PTA)(OR = 1.160,95%CI:1.015-1.326,P = 0.029),the longer the survival time.Conclutions Body weight,taking time of traditional Chinese medicine decoction and PTA are the influencing factors of survival time of patients with HCC in BCLC-C stage treated by TACE combined with traditional Chinese medicine.Nutritional support treatment,traditional Chinese medicine treatment and improvement of coagulation function should be given as soon as possible.
transcatheter arterial chemoembolization(TACE)traditional Chinese medicinehepatocellular carcinoma (HCC)BCLC-C stageinfluencing factor
NETL
NSTL
万方数据
